Med24
metabolic-therapy 22. 7. 2026 • 2 min read • BMC cardiovascular disorders (PubMed)

The relationship between C-reactive protein-triglyceride-glucose index and incident cardiometabolic multimorbidity in postmenopausal women: insights from the China Health and Retirement Longitudinal Study (CHARLS).

BACKGROUND: Cardiometabolic multimorbidity (CMM), defined as the coexistence of at least two cardiometabolic diseases, is an increasing public health burden. Postmenopausal women may be particularly vulnerable because menopause-related metabolic and inflammatory changes can intensify cardiometabolic risk. However,...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Cardiometabolic multimorbidity (CMM) represents a growing public health concern, particularly in postmenopausal women due to associated metabolic and inflammatory changes. This study investigated the relationship between the C-reactive protein-triglyceride-glucose index (CTI) and the development of CMM in a cohort of 2972 postmenopausal women aged 45 years or older, followed for an average of 103.53 months. A total of 395 participants developed new-onset CMM during the study period.

Key Statistical Findings

Multivariate Cox regression revealed a significant positive association between CTI and the risk of CMM, with each 1-unit increase in CTI associated with a 95% increase in risk (HR=1.95). The highest quartile of CTI demonstrated a substantially elevated risk of CMM compared to the lowest quartile (HR=3.91).

Sponsored content

Clinical Discrimination and Subgroup Analysis

The Kaplan-Meier curve indicated a higher cumulative incidence of CMM in individuals with higher CTI levels. Subgroup analysis highlighted a stronger association between CTI and CMM in women under 60 years of age. CTI demonstrated moderate discrimination in predicting CMM, adding incremental value to existing risk models, as evidenced by the NRI and IDI. A nomogram incorporating CTI and other variables showed acceptable discrimination. **CTI** was a key factor in predicting the development of **CMM** in this cohort of **postmenopausal women**, and the results were further supported by the **NRI** and **IDI**.

Original Scientific Source
BMC cardiovascular disorders (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement